1-8 of 8
Weigang Tong, MD
Close
Save search
Sort by
Journal Articles

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients

Free
Kelda Gardner, PA-C, MHS, Elihu H. Estey, MD, Weigang Tong, MD, Robert McCroskey, MD, Roland B. Walter, MD PhD MS, Paul C. Hendrie, MD PhD, Bart L. Scott, MD MS, Andrea M. Perdue, PA-C, Mary-Elizabeth M. Percival, MD MS, Heather A. Smith, PA-C, Cody Hammer, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5207.
https://doi.org/10.1182/blood.V128.22.5207.5207
Published: 2016
Journal Articles

Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.

Free
Shaoqing Kuang, Patrick Zweidler-McKay, MD, PhD, Hui Yang, Zhi Hong Fang, PhD, Weigang Tong, MD, PhD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2008) 112 (11): 3372.
https://doi.org/10.1182/blood.V112.11.3372.3372
Published: 2008
Journal Articles

The Combination of a Histone Deacetylase (HDAC) Inhibitor with the BCL-2 Inhibitor GX15-070 Has Synergistic Antileukemia Effect by Inducing Both Apoptotic and Autophagic Pathways.

Free
Yue Wei, PhD, Tapan Kadia, MD, Weigang Tong, MD, PhD, Susan O’Brien, MD, Jean Viallet, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2008) 112 (11): 1633.
https://doi.org/10.1182/blood.V112.11.1633.1633
Published: 2008
Journal Articles

Identification of Multiple Promoter Associated CpG Islands Commonly Methylated in Both Acute Lymphocytic Leukemia (ALL) and Chronic Lymphocytic Leukemia(CLL) Using Novel Genome-Wide Microarray Technique: Implications for Common Primordial Molecular Pathways in Lymphoid Leukemias.

Free
Weigang Tong, MD, PhD, Shao-Qing Kuang, MD, PhD, William Wierda, MD, PhD, Michael J. Keating, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2008) 112 (11): 2263.
https://doi.org/10.1182/blood.V112.11.2263.2263
Published: 2008
Journal Articles

Genome-Wide Identification of Aberrant Promoter Associated CpG Island Methylation in Acute Lymphoblastic Leukemia.

Free
Shao-qing Kuang, MD, PhD, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Mathew K. Lee, Zhi-Hong Fang, PhD, Jeroslav Jelinek, MD, PhD, Jean-Pierre Issa, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2007) 110 (11): 2127.
https://doi.org/10.1182/blood.V110.11.2127.2127
Published: 2007
Journal Articles

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Free
Shao-qing Kuang, MD, PhD, Zhi-Hong Fang, PhD, Gonzalo Lopez, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2007) 110 (11): 2128.
https://doi.org/10.1182/blood.V110.11.2128.2128
Published: 2007
Journal Articles

Analysis of Class I and II Histone Deacetylase Fails To Identify a Human Leukemia Specific Expression Profile.

Free
Guillermo Garcia-Manero, MD, Andy S. Quesada, MD, PhD, Shirisha Maddipoti, MD, Shaoqing Kuang, MD, Weigang Tong, MD, William G. Wierda, MD, Carlos M. Bueso-Ramos, MD, Hui Yang, MD
Journal: Blood
Blood (2007) 110 (11): 2130.
https://doi.org/10.1182/blood.V110.11.2130.2130
Published: 2007
Journal Articles

Significant Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid and All-Trans Retinoic (ATRA) Acid in Leukemia: Results of a Phase I/II Study.

Free
Andres O. Soriano, MD, Hui Yang, MD, Weigang Tong, MD, Stefan Faderl, MD, William Wierda, MD, Michael Andreeff, MD, Zeev Estrov, MD, Souzanne Ouzounian, MD, Jonathan Clavell, Hagop Kantarjian, MD, Jean-Pierre Issa, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2006) 108 (11): 160.
https://doi.org/10.1182/blood.V108.11.160.160
Published: 2006